CalciMedica is trading 9.74% down now at $0.53 after no verified company-specific announcement dated August 26 or August 27 was identified.
- The latest reported update remains the August 11 second-quarter release, which showed a wider loss and ongoing clinical progress.
- The decline is occurring despite generally positive broader-market conditions, including a higher Nasdaq; the immediate catalyst remains unclear.
- Trading activity and volume data were unavailable in the provided context.